Overview
Dr. Kimberly Cassidy is one of Steptoe’s in-house scientists, bringing over 23 years of professional experience. Kim offers comprehensive advice on a wide range of subjects, with a particular emphasis on Food Contact Notifications (FCNs) and regulatory issues related to the US Food and Drug Administration (FDA). Kim aids clients with navigating the complexities of chemical safety and compliance within the food industry.
Prior to joining Steptoe, Kim spent more than seven years as a regulatory reviewer in the Office of Food Additive Safety at the FDA, specializing in the review and evaluation of chemistry data for FCNs and Pre-Notification Consultations (PNCs) submitted by industry. Additionally, she was adept at calculating exposures to food-contact substances, ensuring compliance with safety standards.
During her time at the FDA, Kim made significant contributions to the field. She developed a new cumulative estimated daily intake and consumption factors for styrene polymers, updated the Divisions' Chemistry Recommendations, which provide essential guidance to the industry. Notably, she was responsible for the most recent update in December 2007.
Kim also served as project lead for the scientific working group meetings of the Wilson Center/GMA Nanotechnology Case Studies on Engineered Food Contact Materials. Additionally, she served as co-chair of the planning committee for the Food and Color Additives/Dietary Supplements Breakout Session for the FDA Nanotechnology Public Meeting in September 2008.
- Kim Cassidy is a Specialist and does not provide legal advice.
- Ph.D., Duke University, 2002, Biological Chemistry
- B.S., College of William & Mary, 1996, High Honors, Chemistry
Areas of Work
Speaking Engagements
- "Technical Considerations Related to the Regulation of Food Contact Materials," Steptoe Food Contact Conference, April 23-24, 2024
- "Scientific Input on Food Contact Safety Determinations and FCN Submissions," Steptoe Food Contact Conference, April 25, 2023
News & Publications
Client Alerts
FDA Proposes to Amend FCN Regulations
January 25, 2022
By: Joan Baughan, Joseph Dages, Daniel C. Rubenstein, Patricia Kinne, Kimberly Cassidy, Ph.D., Jessica Cooper, Ph.D., Sally Mordi
Client Alerts
Federal Court Upholds FDA's Interpretation of Regulatory Framework for GRAS Substances
October 4, 2021
By: Joseph Dages, Joan Baughan, Daniel C. Rubenstein, Patricia Kinne, Kimberly Cassidy, Ph.D., Jessica Cooper, Ph.D., Sally Mordi
Client Alerts
Trying Time: The Food Packaging Supply Chain and Food Contact Material Substitutions
August 3, 2020
Client Alerts
FDA's OTC Drug Review Process Modernized by the CARES Act
April 6, 2020
By: Joan Baughan, Sally Mordi
Client Alerts
Important FDA Activities Related to the COVID-19 Crisis that May Impact Your Business
March 24, 2020
By: Joseph Dages
Client Alerts
China's CFSA Notice Solicits Comments on 10 New Food-Contact Products
February 26, 2020
By: Joan Baughan
Client Alerts
February 26, 2020
Events
Seminars & Events
Complimentary Food Contact Conference
April 29, 2025 - April 30, 2025
Speakers: Joan Baughan, Daniel C. Rubenstein, Joseph Dages, Kimberly Cassidy, Ph.D., Jessica Cooper, Ph.D., Patricia Kinne, Sarah Owen, Ph.D., DABT, Surya Kundu, Melanie A. Ayerh, Anthony G. Hopp, Michael Boucher, Eléonore Mullier, Tom Gillett
Seminars & Events
Complimentary Food Contact Conference
April 23, 2024 - April 24, 2024
Speakers: Joan Baughan, Daniel C. Rubenstein, Joseph Dages, Carly Rolph, Kimberly Cassidy, Ph.D., Jessica Cooper, Ph.D., Patricia Kinne, Tom Gillett, Ruxandra Cana, Daniel Blynn, Anthony G. Hopp, Surya Kundu, Dr. Yan Gu
Keynote Speakers: Dr. Paul Honigfort, Dr. Zhu Lei
Seminars & Events
Complimentary Food Contact Conference
April 25, 2023 - April 26, 2023
Speakers: Joan Baughan, Daniel C. Rubenstein, Joseph Dages, Carly Rolph, Kimberly Cassidy, Ph.D., Jessica Cooper, Ph.D., Patricia Kinne, Glen Rosini, Tom Gillett, Anthony G. Hopp, Ruxandra Cana, Coy Garrison, Abigail Miller, Regulatory Review Chemist, US Food and Drug Administration (FDA), Sean Fischer, Consumer Safety Officer, US Food and Drug Administration (FDA), Daniel Felton, Executive Director, AMERIPEN